NCT06078280View on ClinicalTrials.gov

Feasibility and Efficacy Study of the CardioPulmonary Management (CPM) System in Patients With Chronic Heart Failure (BETA)

NAActive, not recruitingINTERVENTIONAL
Enrollment

13

Participants

Timeline

Start Date

September 27, 2023

Primary Completion Date

November 1, 2024

Study Completion Date

November 1, 2025

Conditions
Heart Failure
Interventions
DEVICE

CardioPumlonary Management System (CPM)

The CPM Device measures and trends a variety of physiologic parameters including thoracic impedance, respiration rate, tidal volume, ECG (electrocardiogram), heart rate, and diastolic heart sounds, all in an unobtrusive patch form factor.

Trial Locations (1)

92262

Desert Oasis Healthcare, Palm Springs

All Listed Sponsors
lead

Analog Device, Inc.

OTHER

NCT06078280 - Feasibility and Efficacy Study of the CardioPulmonary Management (CPM) System in Patients With Chronic Heart Failure (BETA) | Biotech Hunter | Biotech Hunter